Marblegate Acquisition Corp. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
Current assets
Cash
Prepaid expenses
Total Current Assets
Other assets
Deferred offering costs
Cash held in Trust Account
TOTAL ASSETS

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities
Accrued expenses
Accrued offering costs
Promissory note – related party
Accounts payable and accrued expenses
Excise tax payable
Redemptions payable
Income taxes payable
Total Current Liabilities

Deferred legal fees
Working capital loan – related party
Promissory notes – related party
Warrant liability
Deferred underwriting fee payable
Total Liabilities
Class A common stock subject to possible redemption, $0.0001 par value; 200,000,000 shares authorized; 368,879 and 637,605 shares issued and outstanding at $10.93 and $10.63 per share redemption value as of December 31, 2024 and 2023, respectively
Common Stock Class A
Total class A common stock subject to possible redemption, $0.0001 par value; 200,000,000 shares authorized; 368,879 and 637,605 shares issued and outstanding at $10.93 and $10.63 per share redemption value as of December 31, 2024 and 2023, respectively
Stockholders' Deficit
Common stock, value
Common Stock Class A
Common Stock Class B
Additional paid-in capital
Accumulated deficit
Total Stockholders' Deficit
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

Comments